Carla Talarico

1.7k total citations · 2 hit papers
27 papers, 772 citations indexed

About

Carla Talarico is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Carla Talarico has authored 27 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 11 papers in Epidemiology and 9 papers in Health. Recurrent topics in Carla Talarico's work include SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (10 papers) and Vaccine Coverage and Hesitancy (9 papers). Carla Talarico is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (10 papers) and Vaccine Coverage and Hesitancy (9 papers). Carla Talarico collaborates with scholars based in United States, United Kingdom and Belgium. Carla Talarico's co-authors include Bradley K. Ackerson, Katia Bruxvoort, Yi Luo, Lina S. Sy, Hung Fu Tseng, Lei Qian, Julia E. Tubert, Ana Florea, Gina S. Lee and Harpreet S. Takhar and has published in prestigious journals such as Nature Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Carla Talarico

26 papers receiving 763 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

2022 315 citations Hung Fu Tseng, Bradley K. Ackerson et al. Nature Medicine profile →
A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development

2022 106 citations Karen B. Fowler, Magdalena Kaczanowska et al. BMC Public Health profile →

Peers

Countries citing papers authored by Carla Talarico

Since Specialization

Citations

This map shows the geographic impact of Carla Talarico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Talarico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Talarico more than expected).

Fields of papers citing papers by Carla Talarico

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Talarico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Talarico. The network helps show where Carla Talarico may publish in the future.

Co-authorship network of co-authors of Carla Talarico

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Talarico. A scholar is included among the top collaborators of Carla Talarico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Talarico. Carla Talarico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study 2025 ·Journal of Infection ·Jennifer K Quint, Sabada Dube, Lucy Carty, (unknown), Samira Bell, Lance Turtle, Yi Lu, Kathryn Evans, Nahila Justo, Michelle Harley, J Peters, Carla Talarico, Richard McNulty, Ana Goios, (unknown), Rachael A Evans	1
2	Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period 2025 ·Infectious Diseases and Therapy ·Samah Hayek, Joseph Levy, (unknown), Noa Dagan, (unknown), Hadar Duskin‐Bitan, Sabada Dube, Cátia Ferreira, (unknown), Carla Talarico, (unknown), Sudhir Venkatesan, (unknown), Ran D. Balicer, Doron Netzer, Alon Peretz	0
3	Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 2023 ·Nature Communications ·Hung Fu Tseng, Bradley K. Ackerson, Katia Bruxvoort, Lina S. Sy, Julia E. Tubert, Gina S. Lee, Jennifer H Ku, Ana Florea, Yi Luo, (unknown), Soon Kyu Choi, Harpreet S. Takhar, Michael Aragones, Yamuna Devi Paila, (unknown), Carla Talarico, Lei Qian	47
4	A systematic literature review of the economic and healthcare resource burden of cytomegalovirus 2023 ·Current Medical Research and Opinion ·John Diaz‐Decaro, Evan R. Myers, (unknown), (unknown), (unknown), Magdalena Kaczanowska, Elvira Schmidt, (unknown), Carla Talarico, Philip O. Buck	6
5	Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study 2023 ·Vaccine ·Jennifer H Ku, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Julia E. Tubert, Gina S. Lee, Ana Florea, Katia Bruxvoort, Fagen Xie, (unknown), (unknown), Carla Talarico, Hung Fu Tseng	4
6	2292. Measuring Effectiveness against a Shifting Variant Landscape: COVID-19 Example in the Department of Veterans Affairs 2023 ·Open Forum Infectious Diseases ·Scott L. DuVall, Julie A. Lynch, Patrick R. Alba, Michael E. Matheny, Marc A. Suchard, (unknown), (unknown), (unknown), Cátia Ferreira, Sudhir Venkatesan, Carla Talarico, (unknown)	1
7	Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study 2023 ·Vaccine ·Jennifer H Ku, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Julia E. Tubert, Gina S. Lee, Ana Florea, Katia Bruxvoort, Carla Talarico, (unknown), Yun Tian, Hung Fu Tseng	9
8	A systematic literature review on the humanistic burden of cytomegalovirus 2023 ·Current Medical Research and Opinion ·John Diaz‐Decaro, Evan R. Myers, (unknown), (unknown), (unknown), Magdalena Kaczanowska, Elvira Schmidt, (unknown), Carla Talarico, Philip O. Buck	4
9	The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program 2022 ·Vaccines ·Tinevimbo Shiri, (unknown), Carla Talarico, Angharad R. Morgan, (unknown), Philip O. Buck, Phil McEwan, W. David Strain	7
10	Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants breakdown → 2022 ·Nature Medicine ·Hung Fu Tseng, Bradley K. Ackerson, Yi Luo, Lina S. Sy, Carla Talarico, Yun Tian, Katia Bruxvoort, Julia E. Tubert, Ana Florea, Jennifer H Ku, Gina S. Lee, Soon Kyu Choi, Harpreet S. Takhar, Michael Aragones, Lei Qian	315
11	Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study 2022 ·PLoS ONE ·Ana Florea, Lina S. Sy, Yi Luo, Lei Qian, Katia Bruxvoort, Bradley K. Ackerson, Gina S. Lee, Jennifer H Ku, Julia E. Tubert, Yun Tian, Carla Talarico, Hung Fu Tseng	17
12	A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development breakdown → 2022 ·BMC Public Health ·Karen B. Fowler, (unknown), (unknown), (unknown), Magdalena Kaczanowska, (unknown), Elvira Schmidt, (unknown), Carla Talarico, Philip O. Buck, John Diaz‐Decaro	106
13	Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States 2022 ·Vaccine ·Katherine E. Mues, (unknown), Deesha Patel, (unknown), L. Scott Chavers, Carla Talarico, Daina B. Esposito, David Martin, James A. Mansi, Xing Chen, Nicolle M. Gatto, Nicolas Van de Velde	10
14	Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults 2022 ·Clinical Infectious Diseases ·Ana Florea, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Julia E. Tubert, Gina S. Lee, Jennifer H Ku, Katia Bruxvoort, Carla Talarico, (unknown), Yun Tian, Hung Fu Tseng	12
15	Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example 2021 ·Vaccines ·Tinevimbo Shiri, Marc Evans, Carla Talarico, Angharad R. Morgan, (unknown), Philip O. Buck, Phil McEwan, W. David Strain	16
16	Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study 2021 ·The Lancet Regional Health - Americas ·Katia Bruxvoort, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Gina S. Lee, Yun Tian, Ana Florea, Harpreet S. Takhar, Julia E. Tubert, Carla Talarico, Hung Fu Tseng	64
17	Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older 2021 ·Vaccine ·Bradley K. Ackerson, Lei Qian, Lina S. Sy, Katia Bruxvoort, Jun Wu, Yi Luo, John Diaz‐Decaro, Carla Talarico, Hung Fu Tseng	17
18	The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions 2020 ·Human Vaccines & Immunotherapeutics ·Mark Edmondson‐Jones, (unknown), (unknown), (unknown), Emma Medin, Yang Feng, Carla Talarico	11
19	The choice of analytical methodology can alter conclusions regarding herd effects of paediatric pneumococcal vaccination programmes 2018 ·Vaccine ·(unknown), Carla Talarico, Kaatje Bollaerts, William P. Hausdorff, (unknown)	2
20	Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain 2017 ·European Journal of Pediatrics ·(unknown), Amparo Escribano Montaner, Juan García de Lomas, (unknown), Oscar A. Cruz, (unknown), (unknown), (unknown), (unknown), Yang Feng, Melissa K. Van Dyke, (unknown), Pilar Garcı́a-Corbeira, Carla Talarico	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact